Tuberculosis is associated with sputum metabolome variations, irrespective of patient sex or HIV status: an untargeted GCxGC-TOFMS study
Open Access
- 7 June 2023
- journal article
- research article
- Published by Springer Nature in Metabolomics
- Vol. 19 (6) , 1-11
Abstract
Introduction: Various studies have identified TB-induced metabolome variations. However, in most of these studies, a large degree of variation exists between individual patients. Objectives: To identify differential metabolites for TB, independent of patients’ sex or HIV status. Methods: Untargeted GCxGC/TOF-MS analyses were applied to the sputum of 31 TB + and 197 TB- individuals. Univariate statistics were used to identify metabolites which are significantly different between TB + and TB- individuals (a) irrespective of HIV status, and (b) with a HIV + status. Comparisons a and b were repeated for (i) all participants, (ii) males only and (iii) females only. Results: Twenty-one compounds were significantly different between the TB + and TB- individuals within the female subgroup (11% lipids; 10% carbohydrates; 1% amino acids, 5% other and 73% unannotated), and 6 within the male subgroup (20% lipids; 40% carbohydrates; 6% amino acids, 7% other and 27% unannotated). For the HIV + patients (TB + vs. TB-), a total of 125 compounds were significant within the female subgroup (16% lipids; 8% carbohydrates; 12% amino acids, 6% organic acids, 8% other and 50% unannotated), and 44 within the male subgroup (17% lipids; 2% carbohydrates; 14% amino acids related, 8% organic acids, 9% other and 50% unannotated). Only one annotated compound, 1-oleoyl lysophosphaditic acid, was consistently identified as a differential metabolite for TB, irrespective of sex or HIV status. The potential clinical application of this compound should be evaluated further. Conclusions: Our findings highlight the importance of considering confounders in metabolomics studies in order to identify unambiguous disease biomarkers.Keywords
Funding Information
- North-West University
This publication has 28 references indexed in Scilit:
- Analysis of Serum Metabolic Profile by Ultra-performance Liquid Chromatography-mass Spectrometry for Biomarkers DiscoveryChinese Medical Journal, 2015
- Lysophosphatidic acid as a lipid mediator with multiple biological actionsThe Journal of Biochemistry, 2014
- Omics Evidence: Single Nucleotide Variants Transmissions on Chromosome 20 in Liver Cancer Cell LinesJournal of Proteome Research, 2013
- Application of1H NMR Spectroscopy-Based Metabolomics to Sera of Tuberculosis PatientsJournal of Proteome Research, 2013
- Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitorsBMC Infectious Diseases, 2013
- New sputum metabolite markers implicating adaptations of the host to Mycobacterium tuberculosis, and vice versaTuberculosis, 2013
- A comparison of four sputum pre-extraction preparation methods for identifying and characterising Mycobacterium tuberculosis using GCxGC-TOFMS metabolomicsJournal of Microbiological Methods, 2012
- Biomarkers of Inflammation, Immunosuppression and Stress Are Revealed by Metabolomic Profiling of Tuberculosis PatientsPLOS ONE, 2012
- The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leakNature Medicine, 2007
- Cytosolic Phospholipase A2 Participates with TNF-α in the Induction of Apoptosis of Human Macrophages Infected with Mycobacterium tuberculosis H37RaThe Journal of Immunology, 2001